Program summary
Introductory program for physiatrists and neurologists on the use of botulinum toxin A for treatment of focal spasticity in adults
Upon completion of this program, participants will be able to:
- Describe the clinical evaluation and treatment options in focal spasticity management
- Identify the botulinum toxins available in Canada
- Discuss the role of botulinum toxin therapy in focal spasticity treatment plans
Scientific Planning Committee Members
- Chris Boulias, MD, PhD, FRCPC
- Colleen O’Connell, MD, FRCPC (Chair)
- Rajiv Reebye, MD, FRCPC
This program is an accredited self‐assessment program (section 3) as defined by the maintenance of certification program of the royal college of physicians & surgeons of Canada and approved by the Canadian association of physical medicine & rehabilitation. You may claim a maximum of 1.0 hour (credits are automatically calculated).
Register to take Courses (Mandatory). If you are already registered, Log in.